CAI Q2 2017 Earnings — Caris Life Sciences, Inc. Revenue & Financial Results | Market Cap Arena

CAICaris Life Sciences, Inc.

$5B

Q2 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$83M+15.4% YoY

Gross Profit

$39M47.1% margin

Operating Income

$23M27.8% margin

Net Income

$13M15.3% margin

EPS (Diluted)

$0.65

QoQ Revenue Growth

+1.5%

Cash Flow

Operating Cash Flow

$40M

Free Cash Flow

-$41M

Stock-Based Comp.

$534,000

Balance Sheet

Total Assets

$2.1B

Total Liabilities

$1.6B

Stockholders' Equity

$480M

Cash & Equivalents

$25M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$83M	$72M	+15.4%
Gross Profit	$39M	$37M	+5.3%
Operating Income	$23M	$19M	+22.8%
Net Income	$13M	$4M	+236.4%